Hans Messersmith

3.1k total citations
26 papers, 1.2k citations indexed

About

Hans Messersmith is a scholar working on Oncology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hans Messersmith has authored 26 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 6 papers in Genetics and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hans Messersmith's work include Glioma Diagnosis and Treatment (6 papers), Brain Metastases and Treatment (5 papers) and Breast Cancer Treatment Studies (4 papers). Hans Messersmith is often cited by papers focused on Glioma Diagnosis and Treatment (6 papers), Brain Metastases and Treatment (5 papers) and Breast Cancer Treatment Studies (4 papers). Hans Messersmith collaborates with scholars based in Canada, United States and Netherlands. Hans Messersmith's co-authors include Andrea Eisen, Maureen Trudeau, Ellen Warner, Petrina A. Causer, Rene Shumak, Donald B. Plewes, Kathleen I. Pritchard, Leela Elavathil, Frances P. O’Malley and Susan Dent and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Internal Medicine.

In The Last Decade

Hans Messersmith

26 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hans Messersmith Canada 14 552 302 292 273 232 26 1.2k
JoAnne Zujewski United States 11 590 1.1× 344 1.1× 294 1.0× 412 1.5× 78 0.3× 13 1.3k
Sang‐Hue Yen Taiwan 23 512 0.9× 250 0.8× 279 1.0× 390 1.4× 108 0.5× 52 1.8k
Joyce Steinberg United States 21 980 1.8× 534 1.8× 253 0.9× 503 1.8× 185 0.8× 58 2.6k
Andreas Kaubisch United States 18 584 1.1× 129 0.4× 149 0.5× 498 1.8× 160 0.7× 66 1.3k
Lior Z. Braunstein United States 20 488 0.9× 739 2.4× 278 1.0× 481 1.8× 297 1.3× 99 1.6k
Katherine L. Baker-Neblett United States 12 328 0.6× 357 1.2× 66 0.2× 553 2.0× 177 0.8× 17 1.4k
Daniel L. Suzman United States 19 1.3k 2.3× 250 0.8× 219 0.8× 352 1.3× 68 0.3× 59 2.0k
Meng Xu‐Welliver United States 24 507 0.9× 321 1.1× 126 0.4× 860 3.2× 234 1.0× 60 1.7k
Carl Schaper United States 13 749 1.4× 1.1k 3.7× 84 0.3× 493 1.8× 191 0.8× 27 1.7k
Peter Ragnhammar Sweden 26 1.3k 2.4× 146 0.5× 461 1.6× 514 1.9× 397 1.7× 66 2.2k

Countries citing papers authored by Hans Messersmith

Since Specialization
Citations

This map shows the geographic impact of Hans Messersmith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Messersmith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Messersmith more than expected).

Fields of papers citing papers by Hans Messersmith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans Messersmith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Messersmith. The network helps show where Hans Messersmith may publish in the future.

Co-authorship network of co-authors of Hans Messersmith

This figure shows the co-authorship network connecting the top 25 collaborators of Hans Messersmith. A scholar is included among the top collaborators of Hans Messersmith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans Messersmith. Hans Messersmith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Blakeley, Jaishri O., Nimish Mohile, Hans Messersmith, et al.. (2025). Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline Rapid Recommendation Update. Journal of Clinical Oncology. 43(18). 2129–2133. 3 indexed citations
2.
Ricker, Charité, Banu Arun, Sara Pirzadeh‐Miller, et al.. (2024). Selection of Germline Genetic Testing Panels in Patients With Cancer: ASCO Guideline Clinical Insights. JCO Oncology Practice. 20(10). 1308–1313. 3 indexed citations
3.
Vikas, Praveen, Hans Messersmith, Carolyn C. Compton, et al.. (2023). Mismatch Repair and Microsatellite Instability Testing for Immune Checkpoint Inhibitor Therapy: ASCO Endorsement of College of American Pathologists Guideline. Journal of Clinical Oncology. 41(10). 1943–1948. 57 indexed citations
4.
Sondak, Vernon K., Michael B. Atkins, Hans Messersmith, et al.. (2023). Systemic Therapy for Melanoma: ASCO Guideline Update Q and A. JCO Oncology Practice. 20(2). 173–177. 10 indexed citations
5.
Schiff, David, Hans Messersmith, Priscilla K. Brastianos, et al.. (2022). Radiation Therapy for Brain Metastases: ASCO Guideline Endorsement of ASTRO Guideline. Journal of Clinical Oncology. 40(20). 2271–2276. 47 indexed citations
6.
Seth, Rahul, et al.. (2022). Systemic Therapy for Melanoma: ASCO Guideline Rapid Recommendation Update. Journal of Clinical Oncology. 40(21). 2375–2377. 5 indexed citations
7.
Mohile, Nimish, Hans Messersmith, Na Tosha Gatson, et al.. (2021). Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline. Neuro-Oncology. 24(3). 358–383. 12 indexed citations
8.
Chang, Susan M., Hans Messersmith, Manmeet S. Ahluwalia, et al.. (2019). Anticonvulsant prophylaxis and steroid use in adults with metastatic brain tumors: summary of SNO and ASCO endorsement of the Congress of Neurological Surgeons guidelines*. Neuro-Oncology. 21(4). 424–427. 21 indexed citations
9.
Chang, Susan M., Hans Messersmith, Manmeet S. Ahluwalia, et al.. (2019). Anticonvulsant Prophylaxis and Steroid Use in Adults With Metastatic Brain Tumors: ASCO and SNO Endorsement of the Congress of Neurological Surgeons Guidelines. Journal of Clinical Oncology. 37(13). 1130–1135. 21 indexed citations
10.
Messersmith, Hans, et al.. (2014). Priority-based initiative for updating existing evidence-based clinical practice guidelines: the results of two iterations. Journal of Clinical Epidemiology. 67(12). 1335–1342. 17 indexed citations
11.
Rabeneck, Linda, R. Bryan Rumble, Michael R. Mills, et al.. (2012). Fecal Immunochemical Tests Compared with Guaiac Fecal Occult Blood Tests for Population-Based Colorectal Cancer Screening. SHILAP Revista de lepidopterología. 26(3). 131–147. 82 indexed citations
12.
Eisen, Andrea, Maureen Trudeau, Wendy Shelley, Hans Messersmith, & Kathleen I. Pritchard. (2008). Aromatase inhibitors in adjuvant therapy for hormone receptor positive breast cancer: A systematic review. Cancer Treatment Reviews. 34(2). 157–174. 65 indexed citations
13.
Madarnas, Yolanda, Maureen Trudeau, Jacob Franek, et al.. (2008). Adjuvant/neoadjuvant trastuzumab therapy in women with HER-2/neu-overexpressing breast cancer: A systematic review. Cancer Treatment Reviews. 34(6). 539–557. 58 indexed citations
14.
Warner, Ellen, Hans Messersmith, Petrina A. Causer, et al.. (2008). Systematic Review: Using Magnetic Resonance Imaging to Screen Women at High Risk for Breast Cancer. Annals of Internal Medicine. 148(9). 671–679. 397 indexed citations
15.
Green, Esther, Gail Macartney, Caroline Zwaal, et al.. (2008). ONLINE Special Article Managing central venous access devices in cancer patients: A practice guideline. Canadian Oncology Nursing Journal. 18(2). 7 indexed citations
16.
Pritchard, Kathleen I., et al.. (2008). In Reply. Journal of Clinical Oncology. 26(15). 2596–2597. 1 indexed citations
17.
Dent, Susan, Hans Messersmith, & Maureen Trudeau. (2007). Gemcitabine in the management of metastatic breast cancer: a systematic review. Breast Cancer Research and Treatment. 108(3). 319–331. 51 indexed citations
18.
Pritchard, Kathleen I., et al.. (2007). HER2/neu in systemic therapy for women with breast cancer: a systematic review. Breast Cancer Research and Treatment. 109(2). 209–229. 71 indexed citations
19.
Kile, James C., Aaron T. Fleischauer, Matthew J. Kuehnert, et al.. (2005). Article. Archives of Pediatrics and Adolescent Medicine. 159(11). 1022–1022. 44 indexed citations
20.
Fleischauer, Aaron T., James C. Kile, Marc Fischer, et al.. (2005). Evaluation of Human-to-Human Transmission of Monkeypox from Infected Patients to Health Care Workers. Clinical Infectious Diseases. 40(5). 689–694. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by JoAnne Zujewski Breakdown of academic impact, for papers by Sang‐Hue Yen Breakdown of academic impact, for papers by Joyce Steinberg Breakdown of academic impact, for papers by Andreas Kaubisch Breakdown of academic impact, for papers by Lior Z. Braunstein Breakdown of academic impact, for papers by Katherine L. Baker-Neblett Breakdown of academic impact, for papers by Daniel L. Suzman Breakdown of academic impact, for papers by Meng Xu‐Welliver Breakdown of academic impact, for papers by Carl Schaper Breakdown of academic impact, for papers by Peter Ragnhammar
Rankless by CCL
2026